Wang W, Indik S, Wasilenko S T, Faschinger A, Carpenter E J, Tian Z, Zhang Y, Wong G K-S, Mason A L
Center of Excellence for Gastrointestinal Inflammation and Immunity Research, University of Alberta, Edmonton, AB, Canada.
Aliment Pharmacol Ther. 2015 Feb;41(4):393-405. doi: 10.1111/apt.13054. Epub 2014 Dec 18.
A human betaretrovirus (HBRV) has been linked with primary biliary cirrhosis (PBC) following the detection of viral particles in biliary epithelium by electron microscopy and cloning of the betaretrovirus genome from biliary epithelium and peri-hepatic lymph nodes. Evidence for viral infection was found in the majority of PBC patients' peri-hepatic lymph node samples. However, less than a third of the liver samples had detectable HBRV, whereas others were unable to detect betaretrovirus infection or noted the presence of virus in the liver of patients with other diagnoses.
To address the hypothesis that the betaretrovirus may be below the limits of detection in the liver, biliary epithelial cells (BEC) were investigated for the evidence of infection.
Ligation-mediated PCR and next generation sequencing were used to detect proviral integrations in liver, lymph nodes and BEC isolated from liver transplant recipients. Hybridisation-based assays were used to detect betaretroviral RNA in BEC.
Unique HBRV integrations and betaretrovirus RNA were detected in the majority of biliary epithelia derived from patients with PBC, autoimmune hepatitis and cryptogenic liver disease but rarely in other liver transplant recipients with primary sclerosing cholangitis and other hepatic disorders. HBRV integrations were commonly found in PBC patients' lymph nodes but rarely in whole liver samples.
Human betaretrovirus infection is frequently observed at the site of disease in patients with primary biliary cirrhosis and also in biliary epithelium of patients with autoimmune hepatitis and cryptogenic liver disease.
在通过电子显微镜在胆管上皮中检测到病毒颗粒并从胆管上皮和肝周淋巴结克隆出β逆转录病毒基因组后,一种人类β逆转录病毒(HBRV)已与原发性胆汁性肝硬化(PBC)相关联。在大多数PBC患者的肝周淋巴结样本中发现了病毒感染的证据。然而,不到三分之一的肝脏样本中可检测到HBRV,而其他研究则未能检测到β逆转录病毒感染,或指出在患有其他诊断疾病的患者肝脏中存在该病毒。
为了验证β逆转录病毒可能在肝脏中低于检测限这一假说,对胆管上皮细胞(BEC)进行了感染证据的研究。
采用连接介导的PCR和下一代测序技术检测从肝移植受者分离的肝脏、淋巴结和BEC中的前病毒整合情况。基于杂交的检测方法用于检测BEC中的β逆转录病毒RNA。
在大多数来自PBC、自身免疫性肝炎和隐源性肝病患者的胆管上皮中检测到独特的HBRV整合和β逆转录病毒RNA,但在患有原发性硬化性胆管炎和其他肝脏疾病的其他肝移植受者中很少检测到。HBRV整合常见于PBC患者的淋巴结中,但在全肝样本中很少见。
在原发性胆汁性肝硬化患者的疾病部位以及自身免疫性肝炎和隐源性肝病患者的胆管上皮中经常观察到人类β逆转录病毒感染。